Mineralys Therapeutics, Inc. (MLYS) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $646.69M | +238.1% |
| 2024 | $191.26M | -20.7% |
| 2023 | $241.15M | +561.4% |
| 2022 | -$52.27M | -128.0% |
| 2021 | -$22.93M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $646.69M | +238.1% |
| 2024 | $191.26M | -20.7% |
| 2023 | $241.15M | +561.4% |
| 2022 | -$52.27M | -128.0% |
| 2021 | -$22.93M | — |